Literature DB >> 17462354

Survival rates in dysvascular lower limb amputees.

J Kulkarni1, S Pande, J Morris.   

Abstract

BACKGROUND: To assess the 5-year and 10-year survival rates of major (above ankle disarticulation level) dysvascular lower limb amputees attending a sub-regional Disablement Services Centre (DSC) specialising in amputee rehabilitation. Also to investigate the association between survival rates, cause of dysvascularity, level of amputation, smoking status and occupational status.
SETTING: The study was undertaken in sub-regional DSC for amputee rehabilitation covering a base population of about 3.5million people. Over 80% of lower limb amputations were done for dysvascularity (peripheral vascular disease, diabetic or combination). All these patients were followed up in the DSC for their prosthetic/amputee rehabilitation. Modular case records of 201 consecutive patients from 1994 to 1995 who had diagnosis of dysvascularity as the cause of major lower limb amputations, were scrutinised regarding their 10-year survival; demographic details, level of lower limb amputations, Above Knee (AK=Transfemoral), Below Knee (BK=Transtibial), smoking status, occupational status, healing of the stump at first assessment, cause of amputation and association of these factors with survival rates.
RESULTS: Of 201 individuals with either AK or BK amputations, 60% (121) had AK amputations and 67% (134) were males, the mean age was 69years of age. Sixty-seven percent (97) had history of smoking, either current 43% (62) or prior 24% (35) smoking, and 59% (68) were skilled or non-skilled manual workers. Fifty-one percent (99) had diagnosis of peripheral vascular disease, whilst 34% (65) had combination of peripheral vascular disease and diabetes, diabetes on its own in 4% (7). In 12% (23) other causes were noted such as embolism, acute ischaemia, venous ulcers, etc. Regarding stumps healing at first assessment, healing was noted in 54% (109) whilst stump was unhealed in 46% (92). The median survival was 48months. Using Cox proportional hazards regression to identify association with survival, the hazard ratio (HR) was significant regarding level of amputation: HR 2.34; 95% confidence interval (CI) (1.58, 3.47), P<0.001 (a recent BK amputation increases the risk by 2.3 compared to a recent AK amputation in diabetic cohort and also in the peripheral vascular disease/diabetes cohort). Hazard ratio was less than 1.0 in bilateral amputees: HR 0.35, 95% CI (0.21, 0.60), P<0.001 (bilateral amputation decreases risk by 0.35).
CONCLUSION: Our study indicates that the median survival remains at 4years, which is similar to the previously published evidence in the Finish study of 1998 and the earlier study from Scotland in 1992. Unlike the previous data, our study indicates that patients with BK amputations have a higher hazard ratio than the AK amputees, and an association with diabetes has poorer prognosis regarding survival.

Entities:  

Year:  2006        PMID: 17462354     DOI: 10.1016/j.ijsu.2006.06.027

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  11 in total

1.  Very low survival rates after non-traumatic lower limb amputation in a consecutive series: what to do?

Authors:  Morten Tange Kristensen; Gitte Holm; Klaus Kirketerp-Møller; Michael Krasheninnikoff; Peter Gebuhr
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-31

2.  Physical Function and Pre-Amputation Characteristics Explain Daily Step Count after Dysvascular Amputation.

Authors:  Matthew J Miller; Paul F Cook; Paul W Kline; Chelsey B Anderson; Jennifer E Stevens-Lapsley; Cory L Christiansen
Journal:  PM R       Date:  2019-04-17       Impact factor: 2.298

3.  Relationships Among Perceived Functional Capacity, Self-Efficacy, and Disability After Dysvascular Amputation.

Authors:  Matthew J Miller; Dawn M Magnusson; Guy Lev; Thomas T Fields; Paul F Cook; Jennifer E Stevens-Lapsley; Cory L Christiansen
Journal:  PM R       Date:  2018-03-24       Impact factor: 2.298

4.  Time-dependent impact of diabetes on mortality in patients after major lower extremity amputation: survival in a population-based 5-year cohort in Germany.

Authors:  Andrea Icks; Marsel Scheer; Stephan Morbach; Jutta Genz; Burkhard Haastert; Guido Giani; Gerd Glaeske; Falk Hoffmann
Journal:  Diabetes Care       Date:  2011-05-03       Impact factor: 19.112

5.  Through knee amputation: technique modifications and surgical outcomes.

Authors:  Frank P Albino; Rachel Seidel; Benjamin J Brown; Charles G Crone; Christopher E Attinger
Journal:  Arch Plast Surg       Date:  2014-09-15

6.  Use of prostheses in lower limb amputee patients due to peripheral arterial disease.

Authors:  Therezinha Rosane Chamlian
Journal:  Einstein (Sao Paulo)       Date:  2014 Oct-Dec

7.  The impact of gender, level of amputation and diabetes on prosthetic fit rates following major lower extremity amputation.

Authors:  Fiona Davie-Smith; Lorna Paul; Natalie Nicholls; Wesley P Stuart; Brian Kennon
Journal:  Prosthet Orthot Int       Date:  2016-07-09       Impact factor: 1.895

8.  Mortality after amputation in dialysis patients is high but not modified by diabetes status.

Authors:  Marielle A Schroijen; Merel van Diepen; Jaap F Hamming; Friedo W Dekker; Olaf M Dekkers
Journal:  Clin Kidney J       Date:  2019-09-23

9.  Is Reoperation Higher Than Expected after Below-the-knee Amputation? A Single-center Evaluation of Factors Associated with Reoperation at 1 Year.

Authors:  Liam H Wong; Erik Woelber; Alden Wyland; Jordan Arakawa; Kenneth R Gundle; Zachary M Working; James E Meeker
Journal:  Clin Orthop Relat Res       Date:  2021-02-01       Impact factor: 4.755

10.  Time Trends in the Incidence of Long-Term Mortality in T2DM Patients Who Have Undergone a Lower Extremity Amputation. Results of a Descriptive and Retrospective Cohort Study.

Authors:  Ana López-de-Andrés; Rodrigo Jiménez-García; Maria D Esteban-Vasallo; Valentin Hernández-Barrera; Javier Aragon-Sánchez; Isabel Jiménez-Trujillo; Javier de Miguel-Diez; Maria A Palomar-Gallego; Martin Romero-Maroto; Napoleón Perez-Farinos
Journal:  J Clin Med       Date:  2019-10-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.